Aortic disease in women

被引:0
|
作者
Becker, Francois [1 ]
机构
[1] Hop Univ Geneve, Serv Angiol & Hemostase, CH-1211 Geneva, Suisse, Switzerland
来源
PRESSE MEDICALE | 2010年 / 39卷 / 02期
关键词
ANEURYSM; DIAMETER; POPULATION; GENDER; RISK; AGE;
D O I
10.1016/j.lpm.2009.04.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Abdominal aortic disease in women is associated with atheromatous processes much more often than with inflammatory arterial diseases (such as Takayasu or Horton). Intramural hematomas and atheromatous ulcers of the aorta, albeil rare, affect os many women os men and hove variable outcomes: some ore resolved with heparin treatment, and others ore fatal. Atherosclerotic stenoses and occlusions limited to the level of the aortoiliac bifurcation are increasingly prevalent and difficult to treat in young women, in part because of their addiction to smoking. After being more or less ignored for a long time, the particularity of atheromatous abdominal aortic aneurysms (AAA) in women is now being recognized. AAA in women are less frequent than in men, but grow faster and have a higher risk of rupture; moreover, cardiovascular disease is generally detected and managed less often in women. Overall mortality from AAA in women is similar to that of breast cancer. The two major risk factors for AAA are, as in men, a direct family history of AAA and smoking, The diagnostic standards for AAA, the criteria for defining progression, and the indications for surgery ore probably not the some as in men, and the smaller initial caliber of women's aortas must be taken into account. Most guidelines today recommend ultrasound screening for AAA for women older than So years with a family history (in a 1(st) degree relative), women aged 60-75 years who ore hypertensive or smoke, and smokers older than 75 years without serious comorbidity and with a life expectancy essentially normal for their age. Monitoring patients with a small AAA (anteroposterior diameter < 40-45 mm) must not be limited only to the aneurysm, but most also include comprehensive management to eliminate modifiable risk factors and thus to reduce cardiovascular and surgical ask (by better preparing the patient for this possibility) as well as to slow the progression of the aneurysm and decrease the risk of its rupture.
引用
收藏
页码:249 / 253
页数:5
相关论文
共 50 条
  • [41] Aortic valve disease
    Nishimura, RA
    CIRCULATION, 2002, 106 (07) : 770 - 772
  • [42] AORTIC VALVULAR DISEASE
    MARTIN, RG
    AYCOCK, P
    HIRSCHOW.BI
    LEWIS, R
    KIRKLIN, JW
    SOUTHERN MEDICAL JOURNAL, 1972, 65 (11) : 1315 - +
  • [43] Treating Aortic Disease
    Etz, Christian D.
    Battelini, Roberto
    THORACIC AND CARDIOVASCULAR SURGEON, 2017, 65 : S200 - S204
  • [44] Aortic valve disease
    Leggett, M
    Otto, CM
    CURRENT OPINION IN CARDIOLOGY, 1996, 11 (02) : 120 - 125
  • [45] THE ASSESSMENT OF AORTIC DISEASE
    CRANSTON, WI
    MITCHELL, JRA
    RUSSELL, RWR
    SCHWARTZ, CJ
    JOURNAL OF ATHEROSCLEROSIS RESEARCH, 1964, 4 (01): : 29 - 39
  • [46] HYPERTENSION AND AORTIC DISEASE
    DECKER, BL
    CASTLEMAN, B
    BUTTRICK, WF
    LEAF, A
    RABKIN, MT
    SHAW, RS
    TOMCHIK, FS
    WILLIAMS, C
    STGOAR, WT
    NEW ENGLAND JOURNAL OF MEDICINE, 1962, 267 (14): : 712 - &
  • [47] SURGERY FOR AORTIC DISEASE
    GUSBERG, RJ
    JOURNAL OF CARDIOVASCULAR DIAGNOSIS AND PROCEDURES, 1994, 12 (01): : 23 - 25
  • [48] Imaging of aortic disease
    Reimer, P.
    Vosshenrich, R.
    Landwehr, P.
    Storck, M.
    RADIOLOGE, 2007, 47 (05): : 443 - 459
  • [49] MicroRNAs in Aortic Disease
    Vavuranakis, Manolis
    Kariori, Maria
    Vrachatis, Dimitrios
    Aznaouridis, Konstantinos
    Siasos, Gerasimos
    Kokkou, Eleni
    Mazaris, Savvas
    Moldovan, Carmen
    Kalogeras, Konstantinos
    Tousoulis, Dimitris
    Stefanadis, Christodoulos
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (13) : 1559 - 1572
  • [50] Statins in Aortic Disease
    Tsigkou, Vasiliki
    Siasos, Gerasimos
    Bletsa, Evanthia
    Panoilia, Maria-Paraskevi
    Papastavrou, Angeliki
    Kokosias, Georgios
    Oikonomou, Evangelos
    Zaromitidou, Marina
    Vavuranakis, Manolis
    Stefanadis, Christodoulos
    Tousoulis, Dimitris
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (46) : 7109 - 7120